Page 67 - Read Online

Page 352 Genvigir et al. J Transl Genet Genom 2020;4:320-55 I http://dx.doi.org/10.20517/jtgg.2020.37

4. da Silva MB, da Cunha FF, Terra FF, Camara NO. Old game, new players: Linking classical theories to new trends in transplant
immunology. World J Transplant 2017;7:1-25.
5. Cooper M, Salvadori M, Budde K, Oppenheimer F, Sollinger H, et al. Enteric-coated mycophenolate sodium immunosuppression in renal
transplant patients: efficacy and dosing. Transplant Rev (Orlando) 2012;26:233-40.
6. Fujiyama N, Miura M, Kato S, Sone T, Isobe M, et al. Involvement of carboxylesterase 1 and 2 in the hydrolysis of mycophenolate
mofetil. Drug Metab Dispos 2010;38:2210-7.
7. Burg M, Säemann MD, Wieser C, Kramer S, Fischer W, et al. Enteric-coated mycophenolate sodium reduces gastrointestinal symptoms
in renal transplant patients. Transplant Proc 2009;41:4159-64.
8. van Gelder T, Hesselink DA. Mycophenolate revisited. Transpl Int 2015;28:508-15.
9. Bernard O, Guillemette C. The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally
occurring variants. Drug Metab Dispos 2004;32:775-8.
10. Meier-Kriesche HU, Shaw LM, Korecka M, Kaplan B. Pharmacokinetics of mycophenolic acid in renal insufficiency. Ther Drug Monit
2000;22:27-30.
11. Shipkova M, Armstrong VW, Oellerich M, Wieland E. Acyl glucuronide drug metabolites: toxicological and analytical implications. Ther
Drug Monit 2003;25:1-16.
12. Picard N, Cresteil T, Prémaud A, Marquet P. Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5. Ther
Drug Monit 2004;26:600-8.
13. Michelon H, König J, Durrbach A, Quteineh L, Verstuyft C, et al. SLCO1B1 genetic polymorphism influences mycophenolic acid
tolerance in renal transplant recipients. Pharmacogenomics 2010;11:1703-13.
14. Picard N, Yee SW, Woillard JB, Lebranchu Y, Le Meur Y, et al. The role of organic anion-transporting polypeptides and their common
genetic variants in mycophenolic acid pharmacokinetics. Clin Pharmacol Ther 2010;87:100-8.
15. Westley IS, Brogan LR, Morris RG, Evans AM, Sallustio BC. Role of Mrp2 in the hepatic disposition of mycophenolic acid and its
glucuronide metabolites: effect of cyclosporine. Drug Metab Dispos 2006;34:261-6.
16. Kobayashi M, Saitoh H, Kobayashi M, Tadano K, Takahashi Y, et al. Cyclosporin A, but not tacrolimus, inhibits the biliary excretion
of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats. J Pharmacol Exp Ther
2004;309:1029-35.
17. Jetter A, Kullak-Ublick GA. Drugs and hepatic transporters: a review. Pharmacol Res 2020;154:104234.
18. Wang J, Figurski M, Shaw LM, Burckart GJ. The impact of P-glycoprotein and Mrp2 on mycophenolic acid levels in mice. Transpl
Immunol 2008;19:192-6.
19. Patel CG, Ogasawara K, Akhlaghi F. Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this
transport is not inhibited by cyclosporine, tacrolimus or sirolimus. Xenobiotica 2013;43:229-35.
20. Wang D, Zou L, Jin Q, Hou J, Ge G, et al. Human carboxylesterases: a comprehensive review. Acta Pharm Sin B 2018;8:699-712.
21. Fujiyama N, Miura M, Satoh S, Inoue K, Kagaya H, et al. Influence of carboxylesterase 2 genetic polymorphisms on mycophenolic acid
pharmacokinetics in Japanese renal transplant recipients. Xenobiotica 2009;39:407-14.
22. Cilião HL, Camargo-Godoy RBO, Souza MF, Zanuto A, Delfino VDA, et al. Polymorphisms in IMPDH2, UGT2B7, and CES2 genes
influence the risk of graft rejection in kidney transplant recipients taking mycophenolate mofetil. Mutat Res Genet Toxicol Environ
Mutagen 2018;836:97-102.
23. Satoh S, Tada H, Murakami M, Tsuchiya N, Li Z, et al. Circadian pharmacokinetics of mycophenolic Acid and implication of genetic
polymorphisms for early clinical events in renal transplant recipients. Transplantation 2006;82:486-93.
24. Genvigir FDV, Campos-Salazar AB, Felipe CR, Tedesco-Silva H Jr, Medina-Pestana JO, et al. CYP3A5*3 and CYP2C8*3 variants
influence exposure and clinical outcomes of tacrolimus-based therapy. Pharmacogenomics 2020;21:7-21.
25. Grinyó J, Vanrenterghem Y, Nashan B, Vincenti F, Ekberg H, et al. Association of four DNA polymorphisms with acute rejection after
kidney transplantation. Transpl Int 2008;21:879-91.
26. Grenda R, Prokurat S, Ciechanowicz A, Piatosa B, Kaliciński P. Evaluation of the genetic background of standard-immunosuppressant-
related toxicity in a cohort of 200 paediatric renal allograft recipients - a retrospective study. Ann Transplant 2009;14:18-24.
27. Varnell CD, Fukuda T, Kirby CL, Martin LJ, Warshaw BL, et al. Mycophenolate mofetil-related leukopenia in children and young adults
following kidney transplantation: influence of genes and drugs. Pediatr Transplant 2017;21:e13033.
28. Jacobson PA, Schladt D, Oetting WS, Leduc R, Guan W, et al; DeKAF investigators. Genetic determinants of mycophenolate-related
anemia and leukopenia after transplantation. Transplantation 2011;91:309-16.
29. Woillard JB, Picard N, Thierry A, Touchard G, Marquet P; DOMINOS study group. Associations between polymorphisms in
target, metabolism, or transport proteins of mycophenolate sodium and therapeutic or adverse effects in kidney transplant patients.
Pharmacogenet Genomics 2014;24:256-62.
30. Genvigir FDV, Nishikawa AM, Felipe CR, Tedesco-Silva H Jr, Oliveira N, et al. Influence of ABCC2, CYP2C8, and CYP2J2
polymorphisms on tacrolimus and mycophenolate sodium-based treatment in brazilian kidney transplant recipients. Pharmacotherapy
2017;37:535-45.
31. Bernard O, Tojcic J, Journault K, Perusse L, Guillemette C. Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7
metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid. Drug Metab Dispos 2006;34:1539-45.
32. Meech R, Hu DG, McKinnon RA, Mubarokah SN, Haines AZ, et al. The UDP-glycosyltransferase (UGT) superfamily: new members,
new functions, and novel paradigms. Physiol Rev 2019;99:1153-222.
33. Inoue K, Miura M, Satoh S, Kagaya H, Saito M, et al. Influence of UGT1A7 and UGT1A9 intronic I399 genetic polymorphisms on